BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38687545)

  • 1. [Update on the Diagnosis and Stratification of Patients with Acute Myeloid Leukemia: An Urgent National Need].
    Jerez J; Briones JL; Buscaglia F; Torres C; Hidalgo S; Guerra MC; Goldschmidt V; Gazitúa R
    Rev Med Chil; 2023 May; 151(5):628-638. PubMed ID: 38687545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting.
    Attardi E; Savi A; Borsellino B; Piciocchi A; Cipriani M; Ottone T; Fabiani E; Divona M; Travaglini S; Pascale MR; Awada H; Durmaz A; Visconte V; Della Porta MG; Venditti A; Maciejewski JP; Gurnari C; Voso MT
    Blood Adv; 2023 Sep; 7(17):5122-5131. PubMed ID: 37327116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia: 2013 update on risk-stratification and management.
    Estey EH
    Am J Hematol; 2013 Apr; 88(4):318-27. PubMed ID: 23526416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvement.
    Bill M; Mrózek K; Giacopelli B; Kohlschmidt J; Nicolet D; Papaioannou D; Eisfeld AK; Kolitz JE; Powell BL; Carroll AJ; Stone RM; Garzon R; Byrd JC; Bloomfield CD; Oakes CC
    J Hematol Oncol; 2021 Jul; 14(1):107. PubMed ID: 34229733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute leukemia in adults].
    Eigendorff E; Hochhaus A
    Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing.
    Mack EKM; Marquardt A; Langer D; Ross P; Ultsch A; Kiehl MG; Mack HID; Haferlach T; Neubauer A; Brendel C
    Haematologica; 2019 Feb; 104(2):277-287. PubMed ID: 30190345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management.
    Estey EH
    Am J Hematol; 2012 Jan; 87(1):89-99. PubMed ID: 22180162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetics and genomics of acute myeloid leukemia.
    Snaith O; Poveda-Rogers C; Laczko D; Yang G; Morrissette JJD
    Best Pract Res Clin Haematol; 2024 Mar; 37(1):101533. PubMed ID: 38490763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia.
    Oran B; Jorgensen JL; Marin D; Wang S; Ahmed S; Alousi AM; Andersson BS; Bashir Q; Bassett R; Lyons G; Chen J; Rezvani K; Popat U; Kebriaei P; Patel K; Rondon G; Shpall EJ; Champlin RE
    Haematologica; 2017 Jan; 102(1):110-117. PubMed ID: 27540139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients.
    Tsai CH; Yao CY; Tien FM; Tang JL; Kuo YY; Chiu YC; Lin CC; Tseng MH; Peng YL; Liu MC; Liu CW; Yao M; Lin LI; Chou WC; Chen CY; Hou HA; Tien HF
    EBioMedicine; 2019 Feb; 40():240-250. PubMed ID: 30662003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia.
    Yang F; Anekpuritanang T; Press RD
    Mol Diagn Ther; 2020 Feb; 24(1):1-13. PubMed ID: 31848884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of minimal residual disease in NPM1-mutated acute myeloid leukemia by next-generation sequencing.
    Salipante SJ; Fromm JR; Shendure J; Wood BL; Wu D
    Mod Pathol; 2014 Nov; 27(11):1438-46. PubMed ID: 24743218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and Therapy of Acute Myeloid Leukemia in the Era of Molecular Risk Stratification.
    Komanduri KV; Levine RL
    Annu Rev Med; 2016; 67():59-72. PubMed ID: 26473413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybridization capture-based next generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysis.
    He R; Devine DJ; Tu ZJ; Mai M; Chen D; Nguyen PL; Oliveira JL; Hoyer JD; Reichard KK; Ollila PL; Al-Kali A; Tefferi A; Begna KH; Patnaik MM; Alkhateeb H; Viswanatha DS
    Mod Pathol; 2020 Mar; 33(3):334-343. PubMed ID: 31471587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia.
    Song GY; Kim HJ; Kim T; Ahn SY; Jung SH; Kim M; Yang DH; Lee JJ; Kim MY; Cheong JW; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Park SK; Kim SH; Choi CK; Kim HJ; Ahn JS; Kim DDH
    Sci Rep; 2024 Apr; 14(1):8517. PubMed ID: 38609396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.
    Kohlmann A; Bacher U; Schnittger S; Haferlach T
    Leuk Lymphoma; 2014 Aug; 55(8):1725-34. PubMed ID: 24144312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice.
    Lin PH; Li HY; Fan SC; Yuan TH; Chen M; Hsu YH; Yang YH; Li LY; Yeh SP; Bai LY; Liao YM; Lin CY; Hsieh CY; Lin CC; Lin CH; Lien MY; Chen TT; Ni YH; Chiu CF
    Cancer Med; 2017 Feb; 6(2):349-360. PubMed ID: 28070990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant.
    Ahn JS; Kim JY; Kim HJ; Kim YK; Lee SS; Jung SH; Yang DH; Lee JJ; Kim NY; Choi SH; Minden MD; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim DD
    Ann Hematol; 2016 Jan; 95(2):301-10. PubMed ID: 26537612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostically important molecular markers in cytogenetically normal acute myeloid leukemia.
    Lin TL; Smith BD
    Am J Med Sci; 2011 May; 341(5):404-8. PubMed ID: 21522052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of acute myeloid leukemia and its impact on treatment.
    Frankfurt O; Licht JD; Tallman MS
    Curr Opin Oncol; 2007 Nov; 19(6):635-49. PubMed ID: 17906465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.